Baxter Healthcare Corporation
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Baxter Healthcare Corporation sits in the top decile of US sponsors by registered trial count (#393 of 15,742 sponsors by registered trial count).
Baxter Healthcare Corporation: 46 sponsored US clinical trials, 1 recruiting.
Baxter Healthcare Corporation sponsors 46 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 34 completed. 12 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 2 trials.
Top-decile sponsor footprint
Baxter Healthcare Corporation ranks in the top decile of sponsors by registered trial count (#393 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
34 of 44 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
46 total, page 1 of 1
Gen 2 Battrode Wear Study
NCT07256951
Tympanic Thermometer Study
NCT06556628
Mobile Cardiac Telemetry (MCT) Study
NCT07158333
A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
NCT06842134
A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)
NCT06842121
PMCF Study for COSEAL® in Gynecologic Surgery
NCT05996809
Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018
NCT06056011
PMCF Study for ADEPT® in LaparoscopicGynecologic Surgery
NCT05811585
DermaClose DUKE Fasciotomy and Wound Study
NCT05330767
Cefazolin PK Study 3g vs 2g
NCT05309304
Oscillation and Lung Expansion (OLE) Therapy for Treatment of Neuromuscular Disease (NMD) Patients
NCT05366010
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)
NCT04555044
Starling Registry Study
NCT04648293
Healthy Volunteer Study to Evaluate the Impact of Various Common Interventions on Venous Pressure Signal Captured by PIVA
NCT04324593
Validation of a Sensor for Non-invasive Measurement of Stroke Volume and Cardiac Output
NCT04255108
Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects
NCT04155814
Observational Study Using the CoVa Monitoring System 3
NCT03884582
Validation of a Sensor for Non-Invasive Measurements
NCT03463148
Remotely Monitoring Patients With Chronic Conditions in Their Home
NCT03207802
Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery
NCT02891070
Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding
NCT02640235
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion
NCT02476994
Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals
NCT02337790
Monitoring Subjects With Fluid-Management Issues In the Home Environment
NCT02190877
Neck-Worn Monitoring Sensor for - A Study for Monitoring Subjects With Fluid-Management Issues During Dialysis
NCT02140905
Effects of IV Chloride Content on Outcomes
NCT02083198
Dosing Study of Amino Acids in Seriously Ill Patients
NCT01923480
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
NCT01410240
Veritas in Non-Bridging Ventral Hernia Repair
NCT01426477
Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis
NCT01234883
Retrospective Analysis of Veritas in Breast Reconstruction
NCT01454713
Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty
NCT01112735
Study of In-line Pressure Using Various Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase (INFUSE-AT1A)
NCT01116102
Efficacy and Safety of FS VH S/D 4 S-apr for Flap Adherence in Rhytidectomy
NCT00999141
Bone Graft Materials Observational Registry
NCT00974623
FS VH S/D 500 S-apr in Vascular Surgery
NCT00892957
The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
NCT00958711
Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase
NCT00807885
Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS VH S/D 4) in Face-Lift Procedures
NCT00708071
Fibrin Sealant for the Sealing of Dura Sutures
NCT00681824
Fibrin Sealant Vascular Surgery Study
NCT00576420
Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery
NCT00559013
Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix
NCT00566943
Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
NCT00157131
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
NCT00161733
Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds
NCT00161759
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 4 |
| Phase 3 | 5 |
| Phase 4 | 7 |
Therapeutic Areas
What is open in the Baxter Healthcare Corporation pipeline
1 recruiting of 46 indexed (2% open); 34 completed (74%).
Phase mix: 12 late (III/IV) vs 9 early (I/II) (balanced across stages).
Top condition: Hypertension (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Baxter Healthcare Corporation: open-pipeline peers nationwide
Peers matched on 46 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Baxter Healthcare Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 46 trials (± recruiting share)
- ImmunityBio · 46 trials · 17% recruiting
- National Institute of Nursing Research (NINR) · 46 trials · 0% recruiting
- University of Maryland, College Park · 46 trials · 22% recruiting
- New York Medical College · 47 trials · 34% recruiting
Sponsors near 2% open enrollment (± trial volume)
- Centers for Disease Control and Prevention · 2% recruiting · 139 trials
- USDA, Western Human Nutrition Research Center · 2% recruiting · 47 trials
- Sun Pharmaceutical Industries · 2% recruiting · 48 trials
- NSABP Foundation · 2% recruiting · 44 trials
Related
What to do with this Baxter Healthcare Corporation page
46 registered trials is a research-attention snapshot, not an endorsement of Baxter Healthcare Corporation or any single study.
- 1 of Baxter Healthcare Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Baxter Healthcare Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Baxter Healthcare Corporation pipeline card: 46 registered trials from official public datasets.Report a data error.